Abstract
Objective To determine if preincubation with prostaglandin E1 (PGE1) and E2 (PGE2) enhances
oxytocin-induced myometrial contractility in vitro.
Study Design Myometrial strips from 13 women were incubated with PGE1 (10−5 mol/L or 10−6 mol/L), PGE2 (10−5 mol/L or 10−6 mol/L) or solvent before adding cumulative concentrations of oxytocin (10−10 to 10−6 mol/L). The area under the contraction curve was calculated after addition of each
agent. One- and two-way analysis of variance was used for comparison (significance
p < 0.05).
Results PGE2 10−5 mol/L reduced response to oxytocin 10−9 to 10−6 mol/L (p < 0.05). PGE2 reduced spontaneous myometrial contractility as compared with PGE1
(p < 0.05). A dose-dependent negative effect of prostaglandins was detected on oxytocin
10−8 mol/L (10−5 mol/L > 10−6 mol/L; p < 0.05).
Conclusion Contrary to the hypothesis, neither PGE1 nor PGE2 enhanced oxytocin-induced myometrial
contractility; in fact, PGE2 decreased contractility.
Keywords
prostaglandin E1 - prostaglandin E2 - oxytocin - uterine contractility - organ chamber